MD
Molbio Diagnostics Limited
NSE: MOLBIOINE869T01028·Healthcare·www.molbiodiagnostics.com ↗·Mcap ₹15,101 Cr·Listed 2026
₹1,246.00▼ ₹0.20  (−0.02%)
52W: ₹926 – ₹1,687 · Vol: 5.4L shares · Close 25 Sept
Set Alert

News & Filings

NSE filings · newest first · 2 on record

Fri, 25 Sept, 2026

Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27.
Board outcomeOutcome of Board Meeting13:29 IST PDF 491.70 KB XBRL

Thu, 17 Sept, 2026

Schedule of meet to be held on Tuesday, September 22, 2026 at 11.00 A.M.(IST) onwards.
Investor meetAnalysts/Institutional Investor Meet/Con. Call Updates15:12 IST PDF 421.10 KB XBRL
Source: NSE corporate announcements, as filed by the company. Times are IST. Press coverage is not included yet.
Filing activity · 30 days
2filings · +2 vs the 30 days before
● Board & AGM 1● Investor meets 1
NSE filings by type. Press coverage and sentiment are not included yet.
Material vs routine · 90 days
Material events 1 in 90 days
25 SeptBoard outcome Outcome of Board Meeting held on September 25, 2026 for re-appointment of M/s K. S. Kamalakara & Co, Cost Accountants as the Cost Auditor of the Company for FY 2026-27. PDF
Routine disclosures 1
investor meets 1
Split by NSE filing category: business events (results, ratings, deals, leadership, capital actions, regulatory) versus schedules, notices and general updates. Not a view on importance.
Corporate Actions
loading…